127 related articles for article (PubMed ID: 35387659)
1. Downregulation of B3GNT6 is a predictor of poor outcomes in patients with colorectal cancer.
Xiao S; Yang C; Zhang Y; Lai C
World J Surg Oncol; 2022 Apr; 20(1):110. PubMed ID: 35387659
[TBL] [Abstract][Full Text] [Related]
2. Downregulated SPINK4 is associated with poor survival in colorectal cancer.
Wang X; Yu Q; Ghareeb WM; Zhang Y; Lu X; Huang Y; Huang S; Sun Y; Lin J; Liu J; Chi P
BMC Cancer; 2019 Dec; 19(1):1258. PubMed ID: 31888570
[TBL] [Abstract][Full Text] [Related]
3. Upregulated NLGN1 predicts poor survival in colorectal cancer.
Yu Q; Wang X; Yang Y; Chi P; Huang J; Qiu S; Zheng X; Chen X
BMC Cancer; 2021 Aug; 21(1):884. PubMed ID: 34340665
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer.
Lu C; Liao W; Huang Y; Huang Y; Luo Y
BMC Gastroenterol; 2022 Apr; 22(1):207. PubMed ID: 35473611
[TBL] [Abstract][Full Text] [Related]